S&P 500   4,550.58 (-0.09%)
DOW   35,430.42 (+0.04%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.42%)
BABA   74.67 (-2.70%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.65%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+7.01%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
S&P 500   4,550.58 (-0.09%)
DOW   35,430.42 (+0.04%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.42%)
BABA   74.67 (-2.70%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.65%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+7.01%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
S&P 500   4,550.58 (-0.09%)
DOW   35,430.42 (+0.04%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.42%)
BABA   74.67 (-2.70%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.65%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+7.01%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
S&P 500   4,550.58 (-0.09%)
DOW   35,430.42 (+0.04%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.42%)
BABA   74.67 (-2.70%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.65%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+7.01%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)

Globe Life Stock Price, News & Analysis (NYSE:GL)

$120.26
-0.02 (-0.02%)
(As of 04:31 PM ET)
Compare
Today's Range
$120.10
$120.92
50-Day Range
$108.35
$121.34
52-Week Range
$102.23
$123.85
Volume
446,443 shs
Average Volume
517,678 shs
Market Capitalization
$11.32 billion
P/E Ratio
12.88
Dividend Yield
0.75%
Price Target
$134.38

Globe Life MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
11.2% Upside
$134.38 Price Target
Short Interest
Healthy
1.18% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.24
Upright™ Environmental Score
News Sentiment
0.30mentions of Globe Life in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$9.55 M Sold Last Quarter
Proj. Earnings Growth
7.92%
From $10.60 to $11.44 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.14 out of 5 stars

Finance Sector

19th out of 854 stocks

Life Insurance Industry

3rd out of 19 stocks


GL stock logo

About Globe Life Stock (NYSE:GL)

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole, term, and other life insurance products; Medicare supplement and supplemental health insurance products, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.

GL Stock Price History

GL Stock News Headlines

Buffett's latest portfolio additions, trims and cuts in Q3 (GL)
Buffett's Berkshire latest Q3 moves: Acquires Sirius XM, Atlanta Braves; trims HP, Chevron, Amazon; holds onto Apple, Bank of America.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Why Is Globe Life (GL) Up 6.1% Since Last Earnings Report?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Globe Life Inc GL
What 6 Analyst Ratings Have To Say About Globe Life
The Half Known Life
Should Value Investors Consider Globe Life (GL) Stock?
The Globe Life Inc (GL) Company: A Short SWOT Analysis
See More Headlines
Receive GL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Globe Life and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 11/1 Dividend
10/05/2023
Last Earnings
10/25/2023
Dividend Payable
11/01/2023
Today
11/29/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/07/2024

Industry, Sector and Symbol

Industry
Life insurance
Sub-Industry
N/A
Sector
Finance
Employees
3,543
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$134.38
High Stock Price Target
$160.00
Low Stock Price Target
$118.00
Potential Upside/Downside
+11.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
8 Analysts

Profitability

Net Income
$739.70 million
Pretax Margin
17.90%

Debt

Sales & Book Value

Annual Sales
$5.21 billion
Cash Flow
$14.61 per share
Book Value
$49.13 per share

Miscellaneous

Free Float
90,026,000
Market Cap
$11.32 billion
Optionable
Optionable
Beta
0.78
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report














GL Stock Analysis - Frequently Asked Questions

Should I buy or sell Globe Life stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Globe Life in the last twelve months. There are currently 3 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" GL shares.
View GL analyst ratings
or view top-rated stocks.

What is Globe Life's stock price target for 2024?

8 analysts have issued 1-year price objectives for Globe Life's shares. Their GL share price targets range from $118.00 to $160.00. On average, they anticipate the company's share price to reach $134.38 in the next twelve months. This suggests a possible upside of 11.7% from the stock's current price.
View analysts price targets for GL
or view top-rated stocks among Wall Street analysts.

How have GL shares performed in 2023?

Globe Life's stock was trading at $120.55 at the start of the year. Since then, GL shares have decreased by 0.2% and is now trading at $120.26.
View the best growth stocks for 2023 here
.

Are investors shorting Globe Life?

Globe Life saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 1,090,000 shares, a decline of 14.8% from the October 31st total of 1,280,000 shares. Based on an average trading volume of 526,600 shares, the short-interest ratio is presently 2.1 days. Currently, 1.2% of the company's stock are short sold.
View Globe Life's Short Interest
.

When is Globe Life's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 7th 2024.
View our GL earnings forecast
.

How were Globe Life's earnings last quarter?

Globe Life Inc. (NYSE:GL) posted its earnings results on Wednesday, October, 25th. The company reported $2.71 earnings per share for the quarter, beating analysts' consensus estimates of $2.65 by $0.06. The firm had revenue of $1.38 billion for the quarter, compared to analyst estimates of $1.39 billion. Globe Life had a net margin of 16.95% and a trailing twelve-month return on equity of 22.60%. The business's quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the company posted $2.15 earnings per share.
Read the conference call transcript
.

How often does Globe Life pay dividends? What is the dividend yield for Globe Life?

Globe Life declared a quarterly dividend on Tuesday, November 14th. Shareholders of record on Friday, January 5th will be given a dividend of $0.225 per share on Thursday, February 1st. This represents a $0.90 annualized dividend and a dividend yield of 0.75%. The ex-dividend date is Thursday, January 4th.
Read our dividend analysis for GL
.

Is Globe Life a good dividend stock?

Globe Life (NYSE:GL) pays an annual dividend of $0.90 per share and currently has a dividend yield of 0.74%. The company has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 9.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GL will have a dividend payout ratio of 7.87% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for GL.

What guidance has Globe Life issued on next quarter's earnings?

Globe Life updated its FY24 earnings guidance on Wednesday, October, 25th. The company provided EPS guidance of $11.00-11.60 for the period, compared to the consensus earnings per share estimate of $11.36.

What other stocks do shareholders of Globe Life own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Globe Life investors own include AT&T (T), AbbVie (ABBV), Chevron (CVX), International Business Machines (IBM), Intel (INTC), Johnson & Johnson (JNJ), Exxon Mobil (XOM), JPMorgan Chase & Co. (JPM), Coca-Cola (KO) and RTX (RTX).

Who are Globe Life's major shareholders?

Globe Life's stock is owned by a number of institutional and retail investors. Top institutional investors include JPMorgan Chase & Co. (4.51%), Boston Partners (2.52%), FMR LLC (2.53%), Invesco Ltd. (2.02%), Morgan Stanley (1.21%) and Northern Trust Corp (1.01%). Insiders that own company stock include Carol A Mccoy, Charles E Adair, Cheryl Alston, Christopher Todd Moore, David Kendall Carlson, Frank M Svoboda, Frank M Svoboda, Gary L Coleman, James Eric Mcpartland, James Matthew Darden, Jason A Harvey, Jennifer Allison Haworth, John Henry Rogers, Jr, Kenneth J Matson, Larry M Hutchison, Melissa Jane Buchan, Michael Clay Majors, Michael Shane Henrie, Pierre Beaurang, Robert Brian Mitchell, Robert W Ingram, Robert W Ingram, Steven John Dichiaro, Steven Kelly Greer and Terren S Peizer.
View institutional ownership trends
.

How do I buy shares of Globe Life?

Shares of GL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:GL) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -